Kasman, Ian

Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis

Ridgway, J., Zhang, G., Wu, Y., Stawicki, S., Liang, W.-C., Chanthery, Y., Kowalski, J., Watts, R. J., Callahan, C., Kasman, I., et al. (2006) · Nature

Angiogenesis and VEGF in CancerDevelopmental Biology and Gene Regulation

Cited by 986

An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy

Chung, A. S., Wu, X., Zhuang, G., Ngu, H., Kasman, I., Zhang, J., Vernes, J.-M., Jiang, Z., Meng, Y. G., Peale, F. V., et al. (2013) · Nature Medicine

Angiogenesis and VEGF in CancerCancer Immunotherapy and Biomarkers

Cited by 445

Intermittent Administration of MEK Inhibitor GDC-0973 plus PI3K Inhibitor GDC-0941 Triggers Robust Apoptosis and Tumor Growth Inhibition

Hoeflich, K. P., Merchant, M., Orr, C., Chan, J., Den Otter, D., Berry, L., Kasman, I., Koeppen, H., Rice, K., Yang, N.-Y., et al. (2012) · Cancer Research

Melanoma and MAPK PathwaysPI3K/AKT/mTOR signaling in cancer

Cited by 242